These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 21897078)
1. [Clinical analysis of 3 cases with primary splenic diffuse large B-cell lymphoma]. Tanaka M; Tsunoda S; Inoue K; Izumi T; Yamamoto T; Hoshi S; Hirabayashi K; Igarashi S; Akutsu M; Kano Y Rinsho Ketsueki; 2011 Aug; 52(8):703-7. PubMed ID: 21897078 [TBL] [Abstract][Full Text] [Related]
2. Addition of rituximab to standard chemotherapy improves the survival of both the germinal center B-cell-like and non-germinal center B-cell-like subtypes of diffuse large B-cell lymphoma. Fu K; Weisenburger DD; Choi WW; Perry KD; Smith LM; Shi X; Hans CP; Greiner TC; Bierman PJ; Bociek RG; Armitage JO; Chan WC; Vose JM J Clin Oncol; 2008 Oct; 26(28):4587-94. PubMed ID: 18662967 [TBL] [Abstract][Full Text] [Related]
3. [Treatment of primary mediastinal large B-cell lymphomas]. Schneider T; Tóth E; Molnár Z; Várady E; Deák B; Horváth A; Horváth GI; Eid H; Schneider K; Lovey J; Keresztes S; Esik O; Lengyel Z; Rosta A Orv Hetil; 2004 Dec; 145(50):2531-7. PubMed ID: 15662753 [TBL] [Abstract][Full Text] [Related]
4. [Mediastinal large B-cell lymphoma. A retrospective anatomic-clinical study of 26 cases]. Tchen N; Eghbali H; Soubeyran P; Trojani M; Richaud P; Bonnel C; Quénel-Tueux N; Hoerni B Bull Cancer; 1997 Jul; 84(7):704-8. PubMed ID: 9339196 [TBL] [Abstract][Full Text] [Related]
5. [Treatment of aggressive non-Hodgkin's lymphoma with the ProMACE- CytaBOM protocol]. Mihaljević B; Jancić-Nedeljkov R; Sretenović M; Milivojević G; Janković S; Petrović M Srp Arh Celok Lek; 1998; 126(9-10):345-8. PubMed ID: 9863405 [TBL] [Abstract][Full Text] [Related]
6. Primary penile diffuse large B cell lymphoma treated by local excision followed by rituximab-containing chemotherapy. Kim HY; Oh SY; Lee S; Lee DM; Kim SH; Kwon HC; Hong SH; Yoon JH; Kim HJ Acta Haematol; 2008; 120(3):150-2. PubMed ID: 19039206 [TBL] [Abstract][Full Text] [Related]
7. [Primary non-Hodgkin's lymphoma of the paranasal sinuses: a report of 14 cases]. Su ZY; Zhang DS; Zhu MQ; Shi YX; Jiang WQ Ai Zheng; 2007 Aug; 26(8):919-22. PubMed ID: 17697560 [TBL] [Abstract][Full Text] [Related]
8. [Effective combined modality therapy for a patient with primary adrenal lymphoma]. Shirao S; Kuroda H; Kida M; Watanabe H; Matsunaga T; Niitsu Y; Konuma Y; Hirayama Y; Kohda K Rinsho Ketsueki; 2006 Mar; 47(3):204-9. PubMed ID: 16629485 [TBL] [Abstract][Full Text] [Related]
9. Primary diffuse large B-cell lymphoma of the mandible. A case report. Pié-Sánchez J; Petit J; Figueiredo R; Gay-Escoda C Minerva Stomatol; 2011; 60(1-2):87-92. PubMed ID: 21252853 [TBL] [Abstract][Full Text] [Related]
10. Primary bone marrow diffuse large B cell lymphoma: a case series and review. Chang H; Hung YS; Lin TL; Wang PN; Kuo MC; Tang TC; Wu JH; Dunn P; Shih LY Ann Hematol; 2011 Jul; 90(7):791-6. PubMed ID: 21181164 [TBL] [Abstract][Full Text] [Related]
11. Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosis. Hainsworth JD; Wolff SN; Stein RS; Greer JP; Cousar JB; Greco FA Cancer Treat Rep; 1986 Aug; 70(8):953-8. PubMed ID: 3015406 [TBL] [Abstract][Full Text] [Related]
12. Treatment results of tonsillar lymphoma: a 10-year experience. Mohammadianpanah M; Omidvai S; Mosalei A; Ahmadloo N Ann Hematol; 2005 Apr; 84(4):223-6. PubMed ID: 15042316 [TBL] [Abstract][Full Text] [Related]
13. Rituximab in combination with CHOP chemotherapy for the treatment of diffuse large B cell lymphoma in China: a 10-year retrospective follow-up analysis of 437 cases from Shanghai Lymphoma Research Group. Li X; Liu Z; Cao J; Hong X; Wang J; Chen F; Wang C; Zou S; Li J; Shen Z Ann Hematol; 2012 Jun; 91(6):837-45. PubMed ID: 22160255 [TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of cyclophosphamide, adriamycin, vincristine, prednisone and rituximab in patients with human immunodeficiency virus-associated diffuse large B-cell lymphoma: results of a phase II trial. Ribera JM; Oriol A; Morgades M; González-Barca E; Miralles P; López-Guillermo A; Gardella S; López A; Abella E; García M; Br J Haematol; 2008 Feb; 140(4):411-9. PubMed ID: 18162120 [TBL] [Abstract][Full Text] [Related]
15. [Efficacy of rituximab-containing salvage regimens on relapsed or refractory B-cell non-Hodgkin's lymphoma]. Huang HQ; Bu Q; Xia ZJ; Lin XB; Wang FH; Li YH; Peng YL; Pan ZH; Wang SS; Lin TY; Jiang WQ; Guan ZZ Ai Zheng; 2006 Apr; 25(4):486-9. PubMed ID: 16613686 [TBL] [Abstract][Full Text] [Related]
16. EBV-positive diffuse large B-cell lymphoma of the elderly: a case series from Peru. Beltran BE; Castillo JJ; Morales D; de Mendoza FH; Quinones P; Miranda RN; Gallo A; Lopez-Ilasaca M; Butera JN; Sotomayor EM Am J Hematol; 2011 Aug; 86(8):663-7. PubMed ID: 21761432 [TBL] [Abstract][Full Text] [Related]
17. Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia. Sehn LH; Donaldson J; Chhanabhai M; Fitzgerald C; Gill K; Klasa R; MacPherson N; O'Reilly S; Spinelli JJ; Sutherland J; Wilson KS; Gascoyne RD; Connors JM J Clin Oncol; 2005 Aug; 23(22):5027-33. PubMed ID: 15955905 [TBL] [Abstract][Full Text] [Related]
18. High Ki-67 expression in diffuse large B-cell lymphoma patients with non-germinal center subtype indicates limited survival benefit from R-CHOP therapy. Li ZM; Huang JJ; Xia Y; Zhu YJ; Zhao W; Wei WX; Jiang WQ; Lin TY; Huang HQ; Guan ZZ Eur J Haematol; 2012 Jun; 88(6):510-7. PubMed ID: 22413767 [TBL] [Abstract][Full Text] [Related]
19. [Clinical features of 89 patients with primary non-Hodgkin's lymphoma of the tonsil]. Qin Y; Shi YK; He XH; Yang JL; Yang S; Yu YX; Li B; Wang QL; Zhou LQ; Sun Y Ai Zheng; 2006 Apr; 25(4):481-5. PubMed ID: 16613685 [TBL] [Abstract][Full Text] [Related]
20. Primary cardiac lymphoma: clinical, histologic, immunophenotypic, and genotypic features of 5 cases of a rare disorder. Nascimento AF; Winters GL; Pinkus GS Am J Surg Pathol; 2007 Sep; 31(9):1344-50. PubMed ID: 17721189 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]